Get Free Shipping on orders over $49
TOR : Target of Rapamycin - George Thomas

TOR

Target of Rapamycin

By: George Thomas, ‎David M. Sabatini, ‎Michael N. Hall

eText | 6 December 2012 | Edition Number 1

At a Glance

eText


$319.00

or 4 interest-free payments of $79.75 with

 or 

Instant online reading in your Booktopia eTextbook Library *

Why choose an eTextbook?

Instant Access *

Purchase and read your book immediately

Read Aloud

Listen and follow along as Bookshelf reads to you

Study Tools

Built-in study tools like highlights and more

* eTextbooks are not downloadable to your eReader or an app and can be accessed via web browsers only. You must be connected to the internet and have no technical issues with your device or browser that could prevent the eTextbook from operating.
 TOR, the Target of Rapamycin was discovered a little over ten years ago in a genetic screen in S. cerevisiae in search of mutants resistant to the cytostatic effects of the antimycotic, rapamycin. Recent studies have placed TOR at the interface between nutrient sensing and the regulation of major anbolic and catabolic responses. The editors have gathered the leading figures in the field of TOR and its role in cellular homeostasis and human diseases.
on
Desktop
Tablet
Mobile

More in Medical Microbiology & Virology

Integrated Food Safety - Mohamed Al-Farsi

eBOOK

Roles of Mitophagy in Cancer Regulation - Ashok Kumar Pandurangan

eBOOK

Smart Microbiomes for Personalized Medicine - Jen-Tsung Chen

eBOOK

Just the Plague - Polly Gannon

eBOOK

RRP $22.58

$20.99